Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN for Antitussive therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 30 adverse event reports in the FDA FAERS database where DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN was used for Antitussive therapy.

Most Reported Side Effects for DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,155 17.1% 0 25
Dizziness 759 11.2% 0 16
Diarrhoea 570 8.4% 0 11
Accidental overdose 515 7.6% 2 6
Nausea 408 6.0% 0 20
Overdose 377 5.6% 0 11
Product use in unapproved indication 356 5.3% 0 8
Somnolence 304 4.5% 1 6
Insomnia 259 3.8% 0 8
Feeling abnormal 246 3.6% 0 7
Drug effective for unapproved indication 242 3.6% 0 0
Wrong technique in product usage process 238 3.5% 0 3
Incorrect product administration duration 236 3.5% 0 1
Expired product administered 222 3.3% 0 6
Vomiting 220 3.3% 0 17

Other Indications for DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN

Product used for unknown indication (3,451) Cough (1,472) Nasopharyngitis (500) Respiratory tract congestion (443) Productive cough (294) Nasal congestion (138) Hypersensitivity (108) Covid-19 (93) Secretion discharge (89) Pulmonary congestion (84)

Other Drugs Used for Antitussive therapy

DEXTROMETHORPHAN HYDROBROMIDE (22) DEXTROMETHORPHAN (20) CODEINE (8) BENZONATATE (7) GUAIFENESIN (7) LEVODROPROPIZINE (5)

Related Pages

DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Full Profile All Antitussive therapy Drugs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Demographics DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN Timeline